The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Latest News

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

News All Time

Limited Data for JAK Inhibitors in SSc Described in Study

In patients with systemic sclerosis, JAK inhibitors show comparable effectiveness to standard immunosuppressants, but many stop therapy due to treatment failure or adverse events.

Abrocitinib Boosts Skin Clearance and Itch Relief in AD

Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to dupilumab, a post hoc study shows.

When Patients Arrive With AI Diagnoses

Patients increasingly come to visits with AI-generated ideas and online research, forcing doctors to balance information, uncertainty, and reassurance in real time.

When Patient Self-Scheduling Collides With Acute Care

Many health systems are giving patients the power to schedule appointments and procedures. What happens when that autonomy creates down-stream problems?

Hydrolyzed Rice Formula Effective in Cow’s Milk Allergy

Hydrolyzed rice formula serves as an additional nutritional option for managing cow’s milk protein allergy in infants.

Which Medications Increase Heat-Related Risk in Patients?

During periods of extreme heat, several drug classes can make patients more vulnerable to dehydration, heat exhaustion, and heatstroke.

Maternal RSV Shot Largely Safe, Except for Hypertension Risk

Vaccination against respiratory syncytial virus given late in pregnancy is not linked to adverse birth outcomes but is linked to a slightly increased risk for hypertensive disorders of pregnancy.

US FDA Approves Vera's Kidney Disease Drug

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug to treat ⁠patients with a potentially life-threatening kidney...

Online Care Equals In-Person for Atopic Dermatitis QOL

An online team-based teledermatology model provides quality-of-life improvements equivalent to in-person care, according to the results of a randomized trial.

Advances in Pulmonary Arterial Hypertension: Optimizing Care With the Latest Guidelines and Treatment Approaches

Advances in Pulmonary Arterial Hypertension: Optimizing Care With the Latest Guidelines and Treatment Approaches

Hantavirus Webinar May 12: What You Need to Know

Join us for a live conversation about the evolving cruise ship outbreak

Big Gaps Between Heart Failure Patients' Goals and Clinical Reality, Survey Reveals

Many prioritize comfort but also want intensive therapies

Endovascular Thrombectomy Boosts Outcomes in Medium-Vessel Ischemic Stroke

Chinese randomized trial shows "meaningful improvement" in functional outcomes

Nurse Tortured, Prosecutors Say; Hantavirus Case Critically Ill; Skin Cream Recall

Health news and commentary gathered by MedPage Today staff

Exercise and Blood Pressure; Maternal Occupation and Autism

Also in TTHealthWatch: digoxin for heart failure

Novel Central Line Locking Fluid Reduces Certain Complications in ICU

How clinically meaningful the impact of randomized trial findings is debatable

Recommended News For You

Novel Agent for Chronic GVHD Wins FDA Approval

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

Chemo causes lasting physical decline in breast cancer survivors

A radiotheranostic approach designed to combat aggressive cancers

Top 10 questions about breast cancer answered

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Recommended Articles For You

Precision Diagnostics in Breast Cancer: From Imaging to Genomics 

How Cancer Cells Evade Immune Destruction and the Fight Back 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

A New Hope: Exploring the Benefits of Exenteration for Cancer Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

2.

Lower screening age calls for more tailored bowel cancer surveillance

3.

Radiation therapy for patients with breast cancer

4.

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

5.

Measurable Residual Disease Predicts Real-World AML Relapse

1.

Interpreting Iron Studies: What Your Blood Results Really Mean 

2.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

3.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

4.

Liquid Biopsy in Cancer Screening: An Evidence-Based Review for Clinicians

5.

Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

2.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot